针对自身免疫性疾病的创新细胞疗法:EBMT实践协调和指导委员会基于专家的立场陈述和临床实践建议
Raffaella Greco1,2, Tobias Alexander3, Nicoletta Del Papa4
1Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.
EClinicalMedicine
|February 16, 2024
概括
新型细胞疗法 (CT),包括介质细胞 (MSC),化学抗原受体T细胞 (CART) 和调节性T细胞 (Tregs),在治疗自身免疫性疾病 (ADs) 方面表现有前途. 专家共识为患者护理中最佳使用提供了建议.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞疗法 细胞疗法
- 自免疫性疾病 自免疫性疾病
背景情况:
- 自免疫性疾病 (ADs) 涉及免疫耐受性丧失,导致具有显著发病率和死亡率的慢性疾病.
- 传统的免疫抑制 (IS) 和疾病修饰疗法 (DMT) 往往需要重复使用,并且有局限性.
研究的目的:
- 审查关于AD的细胞疗法 (CT) 的证据和专家实践.
- 开发基于专家的共识和建议,用于MSC,CART和Tregs在AD患者的临床应用.
主要方法:
- 一个国际专家小组审查了当前的文献和专家实践.
- 专注于使用介质细胞 (MSC),化学抗原受体T细胞 (CART) 和调控性T细胞 (Tregs) 的使用.
主要成果:
- 在AD患者中成功采用CT,包括MSC,CART和Tregs.
- 为患者护理的最佳实践制定了共识和建议.
结论:
- 细胞疗法为治疗自身免疫性疾病提供了一个有希望的替代方案.
- 定期更新的专家建议将指导临床医生,科学家和患者.
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Autoimmune Disorders
436
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
436
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
T Cell Activation and Clonal Selection
732
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
732


